Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) EPS (Basic) (2016 - 2017)

Bone Biologics (BBLGW) has disclosed EPS (Basic) for 2 consecutive years, with -$0.71 as the latest value for Q4 2017.

  • Quarterly EPS (Basic) fell 491.67% to -$0.71 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$1.14 through Dec 2017, down 62.86% year-over-year, with the annual reading at -$2.65 for FY2025, 90.85% up from the prior year.
  • EPS (Basic) for Q4 2017 was -$0.71 at Bone Biologics, down from -$0.61 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.26 in Q2 2017, with the low at -$0.71 in Q4 2017.